Symptoms of Low St John's Wort: Causes and Treatment
Deficiency
Symptoms & causes
St John's Wort is a medicinal herb with moderate evidence for mild-to-moderate depression, not a nutrient — no deficiency syndrome exists; critically, it is one of the most dangerous supplement-drug interactors known, inducing CYP3A4 and P-gp and reducing blood levels of dozens of medications including antidepressants, HIV drugs, oral contraceptives, and immunosuppressants.
Searching for 'low St John's Wort symptoms' usually means you're experiencing depression or low mood and wondering if this herb can help. St John's Wort (Hypericum perforatum) is not a vitamin or mineral your body needs—it's a plant with drug-like effects. While some evidence supports its use for mild-to-moderate depression, it carries one of the most dangerous drug interaction profiles in the supplement world, making it incompatible with many common medications including birth control, antidepressants, and transplant drugs.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low St John's Wort (Hypericum perforatum), a flowering plant used since antiquity for mood disorders. Bioactive compounds include hypericin and pseudohypericin (naphthodianthrones with proposed MAO inhibition), hyperforin (a phloroglucinol now considered the primary active compound and a potent inducer of CYP3A4 and P-glycoprotein), and flavonoids. Commercial supplements are standardized to 0.3% hypericin or 5% hyperforin content. Not a nutrient; no RDA or AI established; the body has no physiological requirement for hypericum compounds.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- None attributable to low SJW intake—no deficiency phenotype exists
- If searching 'low St John's Wort symptoms,' the underlying concern is almost certainly depression, anxiety, or mood symptoms—clinical entities requiring evaluation, not attributable to insufficient hypericum intake
Don't wait
See a doctor if
- Persistent low mood or depression warrants clinical evaluation before attributing to 'low SJW'
- Major depressive disorder requires evidence-based treatment (psychotherapy, SSRIs/SNRIs, or combined)
- Do not self-treat clinical depression with SJW as a first-line approach without clinician involvement
- Discontinuation of prescribed antidepressants to switch to SJW must be done under medical supervision due to withdrawal risk and potential serotonin syndrome if washout is inadequate
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No deficiency population exists
- The population most likely to use SJW: adults with mild-to-moderate depression or seasonal affective disorder seeking non-prescription alternatives to SSRIs
- People with anxiety or sleep disorders exploring botanical options
- Individuals seeking to avoid pharmaceutical antidepressants
What causes low St John's Wort (Hypericum perforatum), a flowering plant used since antiquity for mood disorders. Bioactive compounds include hypericin and pseudohypericin (naphthodianthrones with proposed MAO inhibition), hyperforin (a phloroglucinol now considered the primary active compound and a potent inducer of CYP3A4 and P-glycoprotein), and flavonoids. Commercial supplements are standardized to 0.3% hypericin or 5% hyperforin content. Not a nutrient; no RDA or AI established; the body has no physiological requirement for hypericum compounds.
- Not applicable—no deficiency syndrome exists for St John's Wort
How low levels are diagnosed
No diagnostic test for SJW deficiency exists. For depression: the PHQ-9 (Patient Health Questionnaire) is the standard primary care screening tool; formal diagnosis requires clinical interview using DSM-5 criteria.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Not applicable for deficiency. Supplement doses used in depression RCTs: 300 mg standardized extract (0.3% hypericin) three times daily (900 mg/day total)—the most common trial dose. Some trials used up to 1,800 mg/day. Trial duration typically 4 to 12 weeks. Available forms include tablets, capsules, teas, and liquid extracts.
How to keep levels up
Not applicable—no deficiency to prevent.
When to see a clinician
Immediately if taking antidepressants (SSRIs, SNRIs, MAOIs)—risk of serotonin syndromeIf taking HIV medications (protease inhibitors, NNRTIs)—SJW can reduce blood levels to subtherapeuticIf taking cyclosporine or tacrolimus—SJW has caused acute organ rejection episodesIf using oral contraceptives—SJW reduces contraceptive efficacy with risk of unintended pregnancyIf taking warfarin—SJW reduces anticoagulation with risk of thromboembolic eventIf taking digoxin, certain chemotherapy agents, or any CYP3A4-metabolized drugDo not start SJW without consulting a clinician or pharmacist if you take any prescription medication
St John's Wort Is Not a Nutrient and There Is No Such Thing as a Deficiency
If you landed here searching for 'low St John's Wort symptoms,' the real question is almost certainly about depression or persistent low mood—not about a missing plant compound. St John's Wort (Hypericum perforatum) is a botanical medicine with pharmacological properties, not a vitamin, mineral, or essential nutrient your body requires.
The National Center for Complementary and Integrative Health (NCCIH) classifies SJW as a dietary supplement with evidence for mild-to-moderate depression, but your body has no physiological requirement for hypericin, hyperforin, or any other Hypericum compound. There is no Recommended Dietary Allowance, no Adequate Intake level, and no clinical deficiency syndrome.
Depression is a complex clinical entity caused by neurobiological, genetic, and psychosocial factors—not by insufficient Hypericum perforatum intake. If you're experiencing depressive symptoms, the correct framework is a clinical evaluation for mood disorders using validated tools like the PHQ-9, not a supplement intake assessment. Framing depression as a 'SJW deficiency' misunderstands both the condition and the herb.
Bottom line
'Low St John's Wort' has no medical meaning—if the concern is depression or mood symptoms, the correct framework is a clinical evaluation for mood disorders, not a plant supplement intake assessment.
What the Evidence Shows for Depression: Honest Grade and Limitations
St John's Wort has more human trial evidence for depression than most botanical supplements, but the data is messier than supplement marketing suggests. A 2008 Cochrane review of 29 trials found SJW more effective than placebo and similarly effective to standard antidepressants for mild-to-moderate depression, with fewer reported side effects.
However, the limitations matter. Most trials were short—4 to 12 weeks—and excluded people with severe or treatment-resistant depression. The comparison antidepressants varied across studies, and many trials were conducted in German-speaking countries where SJW is prescribed by physicians, potentially introducing expectation bias.
The most important counterpoint: NCCIH's own large, rigorous trial published in JAMA in 2002 found no significant effect of SJW versus placebo on the primary endpoint. This study enrolled 340 people with major depression and used the Hamilton Depression Rating Scale—the gold standard. The result was null. For severe depression, the evidence is consistently unsupportive. For anxiety, some evidence exists but is limited. For seasonal affective disorder, ADHD, and other uses, evidence is insufficient.
- Effective for mild-to-moderate depression in most (but not all) RCTs
- NCCIH's large 2002 trial found no significant benefit versus placebo
- Not effective for severe depression—do not substitute for standard care
- Limited evidence for anxiety; insufficient evidence for SAD, ADHD, and other uses
- Most trials were short (4–12 weeks) and excluded severe depression
Bottom line
SJW has more evidence for mild-to-moderate depression than most supplements, but a large NCCIH-funded RCT showed no benefit versus placebo; it is not effective for severe depression, and the evidence gap between mild-to-moderate and severe cases is clinically critical.
CYP3A4 and P-gp Induction: Why St John's Wort Is One of the Most Dangerous Supplement-Drug Interactors
This is the most clinically important thing to understand about St John's Wort, and it's the reason many clinicians consider it more dangerous than helpful. Hyperforin, the compound now believed to be SJW's primary active ingredient, is a potent inducer of CYP3A4—the liver enzyme responsible for metabolizing roughly 50% of all prescription drugs—and P-glycoprotein, a drug efflux transporter.
Hyperforin activates the pregnane X receptor (PXR), which upregulates CYP3A4 and P-gp expression. The result: drugs metabolized by these pathways are cleared from the body faster, reducing their blood levels by 30% to 70% depending on the drug. This is not a theoretical concern. The FDA issued a public health advisory in 2000 warning about these interactions, and MedWatch has documented serious clinical consequences.
Documented outcomes include acute organ rejection in transplant patients taking cyclosporine, virological failure in HIV patients on antiretrovirals, unintended pregnancy from oral contraceptive failure, and reduced anticoagulation leading to thromboembolic events in patients on warfarin. SJW also reduces blood levels of digoxin, certain chemotherapy agents including irinotecan, and many other drugs. Additionally, SJW has mild serotonin reuptake inhibition that can be additive with SSRIs or SNRIs, creating a risk of serotonin syndrome—a potentially life-threatening condition.
- CYP3A4 induction: reduces blood levels of ~50% of prescription drugs
- P-glycoprotein induction: accelerates drug efflux from cells
- Documented transplant rejection with cyclosporine and tacrolimus
- HIV antiretroviral failure with protease inhibitors and NNRTIs
- Oral contraceptive failure and unintended pregnancy
- Reduced warfarin efficacy with thromboembolic risk
- Serotonin syndrome risk when combined with SSRIs or SNRIs
Bottom line
SJW's enzyme-induction effects can reduce blood levels of roughly 50% of prescription drugs—the interaction risk is not theoretical; documented clinical consequences include organ transplant rejection, HIV treatment failure, unintended pregnancy, thromboembolic events, and chemotherapy failure.
Side Effects of St John's Wort: What the Trials Report
Photosensitivity is St John's Wort's most characteristic adverse effect and the one most commonly omitted from wellness content. Hypericin accumulates in the skin and, when exposed to UV light, can cause phototoxic reactions ranging from erythema to blistering, particularly in fair-skinned individuals. If you take SJW, sun protection is not optional—it's a clinical necessity.
Other side effects reported in trials include dizziness, dry mouth, headache, and gastrointestinal symptoms, though these occur at rates similar to placebo in most studies. Some users report sleep disturbances due to a mild stimulant effect; morning dosing is generally preferred to minimize this.
A critical safety point buried in most consumer content: SJW should not be used by people with bipolar disorder. Case reports and clinical experience indicate it can trigger manic episodes, and this risk is serious enough that many psychiatrists consider bipolar disorder an absolute contraindication. Discontinuation should be gradual—taper over one to two weeks to avoid rebound symptoms, though withdrawal effects are generally milder than with SSRIs.
- Photosensitivity: hypericin-related phototoxicity with UV exposure—use sun protection
- Dizziness, dry mouth, headache, GI symptoms (generally mild and placebo-rate)
- Sleep disturbances: take in the morning to minimize
- Bipolar disorder: may trigger manic episodes—avoid without psychiatrist guidance
- Discontinuation: taper gradually over 1–2 weeks
Bottom line
Photosensitivity is SJW's most characteristic and underreported adverse effect; the bipolar disorder contraindication—risk of triggering mania—is critical clinical information consistently buried in wellness content.
St John's Wort and GLP-1 Therapy: Antidepressant Context and Drug Interaction Risk
Depression and obesity are bidirectionally linked, and many people using GLP-1 medications like semaglutide or tirzepatide have comorbid depression. Some are on SSRIs or SNRIs—adding SJW to this medication regimen creates a real risk of serotonin syndrome. Others, not on antidepressants, may explore SJW for mood support during the caloric restriction of weight loss, which can sometimes lower mood.
Is there a direct interaction between SJW and GLP-1 drugs? Semaglutide is metabolized primarily through general protein degradation pathways, not CYP3A4, so a direct pharmacokinetic interaction is unlikely. However, this narrow reassurance misses the bigger picture: the typical GLP-1 user often takes multiple medications—antihypertensives, statins, oral contraceptives—many of which are CYP3A4 substrates and vulnerable to SJW's enzyme-inducing effects.
If you're using compounded semaglutide or tirzepatide through a telehealth provider like Curex, your prescribing clinician needs a complete medication and supplement history. SJW must be disclosed. The interaction risk isn't with the GLP-1 drug itself in most cases—it's with everything else you might be taking alongside it.
Bottom line
For GLP-1 users on SSRIs, SNRIs, or any CYP3A4-metabolized drug, SJW is contraindicated without explicit clinician clearance; GLP-1 drugs themselves may not interact via CYP3A4, but the broader medication context of most GLP-1 users creates significant SJW interaction risk.
What most pages leave out
Most supplement sites mention St John's Wort drug interactions in passing without conveying the clinical gravity—documented consequences include organ transplant rejection, HIV treatment failure, and unintended pregnancy. The bipolar mania-induction risk is almost universally buried. The photosensitivity mechanism is the adverse effect most commonly omitted from mainstream wellness content. And NCCIH's own large trial showing no benefit versus placebo is rarely mentioned in pro-SJW content.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There are none. St John's Wort is not a nutrient and no deficiency syndrome exists. If you're experiencing depression or mood symptoms, seek clinical evaluation—these are not caused by 'not enough SJW.'
For mild-to-moderate depression, multiple randomized controlled trials show it outperforms placebo and matches some antidepressants in efficacy. However, a large NCCIH-funded trial found no significant benefit versus placebo. It is not effective for severe depression.
SJW interacts with dozens of medications via CYP3A4 and P-gp induction: antidepressants (SSRIs—serotonin syndrome risk), HIV antiretrovirals, oral contraceptives, cyclosporine, tacrolimus, warfarin, digoxin, certain chemotherapy agents, and any CYP3A4-metabolized drug. Consult a pharmacist before use.
Yes. Hypericin, a compound in SJW, accumulates in skin and can cause photosensitive reactions including erythema and phototoxicity with UV exposure. Use sun protection while taking SJW.
No. SJW may trigger manic episodes in bipolar disorder and should be avoided without psychiatrist guidance.
Most clinical trials used 300 mg standardized extract (0.3% hypericin) three times daily, totaling 900 mg per day. The onset of antidepressant effect typically takes 4 to 6 weeks.
Yes. SJW reduces oral contraceptive blood levels via CYP3A4 induction, potentially causing contraceptive failure. Use additional contraception while taking SJW.
Direct GLP-1 drug interaction is unlikely since semaglutide is not CYP3A4-metabolized, but many co-medications in the GLP-1 user population are CYP3A4 substrates. Always disclose SJW to your prescribing clinician.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
What Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrient—no deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isn’t a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient — no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreSymptoms of Low Ashwagandha: Causes and Treatment
Ashwagandha is an adaptogenic herb, not a nutrient. No deficiency syndrome exists. Learn what the evidence shows for stress, thyroid, and safety risks like thyrotoxicosis.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.